Zegalogue .6 mg/.6mL
dasiglucagon · INJECTION, SOLUTION · Novo Nordisk
No Recall History
Plain English
Zegalogue is a injection, solution containing dasiglucagon at .6 mg/.6mL, taken subcutaneous. Manufactured by Novo Nordisk.
Key Facts
- Brand Name
- Zegalogue
- Generic Name
- dasiglucagon
- NDC Code (Product)
0169-1912- Manufacturer
- Novo Nordisk
- Strength
- .6 mg/.6mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA214231
- Drug Class
- Antihypoglycemic Agent [EPC]
- Marketing Start
- 06/26/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Zegalogue used for?
Zegalogue contains dasiglucagon. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Zegalogue a controlled substance?
Zegalogue is not classified as a controlled substance by the DEA.
What is the generic name for Zegalogue?
The generic name for Zegalogue is dasiglucagon. There are no other listed brand versions of dasiglucagon.
What is the NDC code for Zegalogue .6 mg/.6mL?
The NDC (National Drug Code) for Zegalogue .6 mg/.6mL is 0169-1912, listed by Novo Nordisk.
Other Zegalogue Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)